Vertex Pharmaceuticals (NASDAQ:VRTX), a leading biotechnology company known for its cystic fibrosis (CF) treatments, is at a critical juncture as it seeks to diversify its portfolio and maintain its ...

Vertex Pharmaceuticals (NASDAQ: VRTX) has long been known as the company to turn to for life-saving cystic fibrosis (CF) ...

AbbVie, Eli Lilly and Company, Vertex Pharmaceuticals, Thermo Fisher Scientific, and Johnson & Johnson are the five ...

Buying $100 In VRTX: If an investor had bought $100 of VRTX stock 20 years ago, it would be worth $4,232.95 today based on a ...

Bank of America Securities analyst Tazeen Ahmad maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report) today and set a ...

Q4 2024 . Management View. Amgen highlighted its robust performance in 2024, achieving 14 products annualizing over $1 billion in ...

Major indices closed higher on Tuesday as the effects of the new White House administration’s tariffs on a number of its ...

U.S. stock markets have been experiencing heightened volatility due to recent tariff announcements and ongoing concerns about trade policies, which have impacted major indices like the S&P 500 and ...

2-Year U.S. Treasury Note Continuous Contract $102.805-0.008-0.01% 5-Year U.S. Treasury Note Continuous Contract $106.523 0.133 0.12% 10-Year U.S. Treasury Note Continuous Contract $109.172 0.328 ...

Shares of Vertex Pharmaceuticals Inc. VRTX rallied 2.53% to $482.28 Tuesday, on what proved to be an all-around great trading ...